Kathy Brown focuses her practice on complex litigation. Kathy's practice includes professional liability, pharmaceutical, medical device and mass tort litigation. A significant amount of her practice is spent advising national and international clients in all phases of electronic discovery and information management. 

Kathy's professional liability practice includes representing accounting firms in malpractice actions and regulatory matters before the Public Company Accounting Oversight Board, and the Securities and Exchange Commission. Her professional liability experience is enhanced from her twelve years of service on the Supreme Court of Texas, Board of Disciplinary Appeals, where she dealt with a large range of legal ethical issues. Kathy's pharmaceutical and medical device experience includes cases involving breast implants, "Phen-Fen," Enbrel®, methotrexate, phenylpropanolamine (PPA), Cox-2 inhibitors and gadolinium-based contrast agents. Her mass tort and product liability experience, in addition to the product liability aspects of pharmaceutical and medical device cases, also includes cases involving chemical exposure and product liability cases involving automobile, tire and polyethylene pipe.

Kathy's experience includes the development, analysis and/or use of document management and case management databases. She has also handled cases involving claims of negligence, strict liability, intentional torts, wrongful death, wrongful termination, breach of contract, class action and the Texas Deceptive Trade Practices Act (DTPA).

Kathy is a member of DLA Piper's North American Pro Bono Committee.